Precigen (PGEN) News Today $2.76 -0.19 (-6.29%) As of 02:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PGEN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Precigen (NASDAQ:PGEN) Stock Rating Upgraded by JPMorgan Chase & Co.August 18 at 2:04 AM | americanbankingnews.comTop Penny Stocks To Watch Today - August 15thAugust 17 at 4:32 PM | marketbeat.comPrecigen (NASDAQ:PGEN) Sets New 1-Year High - Here's What HappenedAugust 17 at 10:03 AM | marketbeat.comHC Wainwright Issues Negative Outlook for Precigen EarningsAugust 17 at 8:58 AM | marketbeat.comPrecigen (NASDAQ:PGEN) Rating Increased to Neutral at JPMorgan Chase & Co.August 17 at 8:29 AM | marketbeat.comWhat is HC Wainwright's Estimate for Precigen Q3 Earnings?August 16 at 11:06 AM | marketbeat.comPrecigen surges on FDA approval for immunotherapyAugust 16 at 9:27 AM | msn.comPrecigen stock soars after FDA approves first RRP treatmentAugust 16 at 4:25 AM | investing.comJP Morgan Upgrades Precigen (PGEN)August 16 at 4:25 AM | msn.comPrecigen shares jump after US FDA approves first therapy for rare respiratory diseaseAugust 16 at 4:25 AM | msn.comPrecigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos TherapyAugust 16 at 4:25 AM | msn.comHC Wainwright Predicts Precigen's Q3 Earnings (NASDAQ:PGEN)August 16 at 2:17 AM | americanbankingnews.comPrecigen's (PGEN) Buy Rating Reiterated at HC WainwrightAugust 16 at 2:17 AM | americanbankingnews.comPrecigen: This Billion-Dollar Approval Is Still UndervaluedAugust 15 at 4:14 PM | seekingalpha.comPrecigen, Inc. Stock (PGEN) Opinions on FDA Approval of PapzimeosAugust 15 at 1:39 PM | quiverquant.comQPrecigen (NASDAQ:PGEN) Shares Up 7.5% After Better-Than-Expected EarningsAugust 15 at 11:17 AM | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Precigen (NASDAQ:PGEN)August 15 at 8:33 AM | marketbeat.comUS FDA approves Precigen's immunotherapy for rare respiratory diseaseAugust 15 at 8:02 AM | reuters.comPrecigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory PapillomatosisAugust 15 at 7:00 AM | prnewswire.comPrecigen (NASDAQ:PGEN) Trading 7.5% Higher After Earnings BeatAugust 15 at 2:52 AM | americanbankingnews.comPrecigen trading halted, news pendingAugust 14, 2025 | msn.comPrecigen (NASDAQ:PGEN) Releases Earnings Results, Beats Estimates By $0.03 EPSAugust 14, 2025 | marketbeat.comPrecigen, Inc. Reports Q2 2025 Earnings and Strategic FocusAugust 13, 2025 | msn.comPrecigen (PGEN) Projected to Post Earnings on WednesdayAugust 11, 2025 | americanbankingnews.comTraders Buy High Volume of Call Options on Precigen (NASDAQ:PGEN)August 7, 2025 | marketbeat.comPrecigen (PGEN) Expected to Announce Quarterly Earnings on WednesdayAugust 6, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Sees Unusually-High Trading Volume - Still a Buy?July 31, 2025 | marketbeat.comTraders Buy High Volume of Precigen Put Options (NASDAQ:PGEN)July 31, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Trading 10.9% Higher - Here's What HappenedJuly 24, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Shares Cross Below Two Hundred Day Moving Average - What's Next?July 23, 2025 | marketbeat.comHC Wainwright Estimates Precigen's Q1 Earnings (NASDAQ:PGEN)July 15, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Stock Price Up 7.9% - Should You Buy?July 14, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Upgraded at Wall Street ZenJuly 12, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Sees Unusually-High Trading Volume - Should You Buy?July 9, 2025 | marketbeat.comIridian Asset Management LLC CT Sells 656,113 Shares of Precigen, Inc. (NASDAQ:PGEN)July 9, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Shares Up 6.6% - Time to Buy?July 8, 2025 | marketbeat.comPrecigen: August Is Pivotal For This Biotech InnovatorJuly 7, 2025 | seekingalpha.comPrecigen, Inc. (PGEN) Latest Stock News & Headlines - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comPrecigen (NASDAQ:PGEN) Stock Price Passes Above Fifty Day Moving Average - Time to Sell?July 3, 2025 | marketbeat.comPrecigen Announces Key Approvals at Annual MeetingJuly 2, 2025 | theglobeandmail.comPrecigen (NASDAQ:PGEN) Stock Passes Above 50-Day Moving Average - Should You Sell?June 24, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Earns Market Outperform Rating from JMP SecuritiesJune 12, 2025 | marketbeat.comPrecigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutionsJune 12, 2025 | finance.yahoo.comCantor Fitzgerald Estimates Precigen FY2026 EarningsJune 11, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN)May 27, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Downgraded to "Sell" Rating by Wall Street ZenMay 26, 2025 | marketbeat.comFY2025 EPS Estimates for Precigen Cut by Cantor FitzgeraldMay 21, 2025 | marketbeat.comHC Wainwright Decreases Earnings Estimates for PrecigenMay 21, 2025 | marketbeat.comJ.P. Morgan Sticks to Its Sell Rating for Precigen (PGEN)May 20, 2025 | theglobeandmail.comPrecigen, Inc.: Precigen Reports First Quarter 2025 Financial Results and Business UpdatesMay 17, 2025 | finanznachrichten.de Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼0.580.65▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼352▲PGEN Articles Average Week Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGIO News Today IRON News Today DNLI News Today HRMY News Today IDYA News Today MESO News Today ADPT News Today ANIP News Today CGON News Today VCEL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access